Viewing Study NCT00874861


Ignite Creation Date: 2025-12-24 @ 11:51 AM
Ignite Modification Date: 2026-01-01 @ 3:16 PM
Study NCT ID: NCT00874861
Status: COMPLETED
Last Update Posted: 2015-12-08
First Post: 2009-04-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas
Sponsor: Ian F. Pollack, M.D.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module